Summary
Twenty-seven of eighty-eight (30.7%) Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy developed drug related dream phenomena. The patients reported three separate types of new dreams which we have classified as vivid dreams, night terrors and nightmares. These dreams are correlated to the duration of levodopa therapy although the mechanism of their production is unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barbeau, A. L-dopa therapy in Parkinsons disease a critical review of Hines years experience. Can. Med. Assoc. J.101, 59–68 (1969).
Bergonzi, P., Churulla, C., Cianchette, C., Tempesta, E. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: The action of levodopa. Confin. Neurol.36, 5–22 (1974).
Broughton, R. J. Sleep disorders: Disorders of arousal? Science159, 1070 to 1078 (1968).
Castaldo, V., Krynicki, V. E., Crade, M. L-dopa and REM sleep in normal and mentally retarded subjects. Biol. Psychiatry6, 295–299 (1973).
Celesia, C. G., Barr, A. Psychosis and other Psychiatric manifestation of levodopa. Arch. Neurol.23, 193–200 (1970).
Dement, W., Rechtschaffen, A., Gulevich, G. The nature of the narcoleptic sleep attack. Neurology (Minneap.)16, 18–33 (1966).
Fisher, C. F., Kahn, E., Edwards, A., et al. A psychophysiological study of nightmares and night terrors: The suppression of stage 4 night terrors with diazepam. Arch. Gen. Psychiatry28, 252–259 (1973 a).
Fisher, C., Kahe, E., Edwards, A., et al. A psychophysiology study of nightmares and night terrors. I. Physiological aspects of the stage 4 night terror. J. Nerv. Ment. Dis.157, 75–98 (1973 b).
Fisher, C., Kahe, E., Edwards, A., Davis, D. M., Fine, J. A psychophysiological study of nightmares and night terrors. III. Mental content and recall of state 4 night terrors. J. Nerv. Ment. Dis.158, 174–188 (1974).
Flemenbaum, A. Pavor Nocturnus: A complication of single daily tricyclic or neuroleptic dosage. Am. J. Psychiatry133, 570–572 (1976).
Foulkes, D. Dream reports from different stages of sleep. J. Abnorm. Soc. Psychol.65, 14–25 (1962).
Foulkes, D., Vogel, G. Mental activity at sleep onset. J. Abnorm. Psychol.70, 231–243 (1965).
Gastaut, H., Broughton, R. A clinical and polygraphic study of episodic phenomena during sleep. In: Recent Advances in Biological Psychiatry (Mortis, J., ed.), pp. 197–221. New York: Plenum Press. 1965.
Goodwin, F. K. Behavioral effects of levodopa in man. Semin. Psychiatry3, 477–492 (1971).
Goodwin, F. K., Dunner, D. L., Gershon, E. S. Effect of L-dopa treatment on brain serotonin metabolism in depressed patients. Life Sci.10, 750 to 751 (1971).
Holman, R. B., Elliott, G. R., Barchas, J. D. Neuroregulators and sleep mechanisms. In: Serotonin and Behavior (Barchas, J. D., Usdin, E., eds.), pp. 499–520. New York: Academic Press. 1975.
Jus, K., Beland, C., Bouchard, M., et al.: Polygraphic night sleep pattern during chronic single and multiple neuroleptic dose administration. Presented at the meeting of the Society of Biological Psychiatry, New York, 1975.
Kales, A., Kalse, J. D. Sleep disorders. Recent findings in the diagnosis and treatment of disturbed sleep. N. Engl. J. Med.290, 487–499 (1974).
Kales, A., Scharf, M., Tan, T. L. Sleep laboratory and clinical studies of the effects of Tofranil, Valium, and placebo on sleep stages and enuresis. Psychophysiology7, 350–352 (1970).
Kales, A., Ansel, R. D., Markham, C. H., Scharf, M. B., Tan, T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin. Pharmacol. Ther.12, 397 (1971).
Klawans, H. L., Garvin, J. S. Treatment of Parkinsonian with L-dopa. Dis. Nerv. Syst.30, 733–746 (1969).
McDowell, F. H., Markham, C. H., Lee, J. E., Treciokas, L. J., Ansel, R. D. The clinical use of levodopa in the treatment of Parkinson's disease. In: Recent Advances in Parkinson's Disease (McDowell, E. H., Markham, C. H., eds.). Philadelphia: F. A. Davis. 1971.
Moskovitz, C., Moses, H., Klawans, H. L.: Levodopa-induced psychosis: A kindling phenomenon. Am. J. Psychiatry (in press).
Post, R. M., Gillin, J. C., Wyatt, R. J., Goodwin, F. K., Snyder, F., Bunney, W. E. REM sleep suppressing effects of intravenous L-dopa given during sleep. Psychophysiology9, 88 (1972).
Puca, F. M., Bricola, A., Turella, G. Effect of L-dopa or amantadine therapy on sleep spindles in parkinsonism. Electroencephalogr. Clin. Neurophysiol.35, 327–330 (1973).
Rechtschaffen, A., Goodenough, D. R., Shapiro, A. Patterns of sleep talking. Arch. Gen. Psychiatry7, 418–427 (1962).
Rechtschaffen, A., Verdone, P., Wheaton, J. Reports of mental activity during sleep. Can. Psychiatr. Assoc. J.8, 404–414 (1963).
Schmidt, H. S., Knopp, W. Sleep in Parkinson's disease: The effect of L-dopa. Psychophysiology9, 88 (1972).
Spitzer, H., Zarcone, V., Barchas, J., Ryan, R., Smythe, H., Dement, W. Administration of 5-hydroxytryptophan (5-HTP) to a L-dihydroxy-phenylamine (L-dopa) treated patient with Shy-Drager syndrome. Psychophysiology9, 87 (1972).
Wyatt, R. J. Effect of L-dopa on the sleep of man. Nature (Lond.)228, 999–1001 (1970).
Wyatt, R. J. The serotonin-catecholamine-dream bicycle: A clinical study. Biol. Psychiatry5, 33–64 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharf, B., Moskovitz, C., Lupton, M.D. et al. Dream phenomena induced by chronic levodopa therapy. J. Neural Transmission 43, 143–151 (1978). https://doi.org/10.1007/BF01579073
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01579073